38D-13210-57304
3 vaccinations
7 coded responses
25 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 063 / CT
- Registered
- 2021-04-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-27
Dose 1 — Pfizer-BioNTech
-
2021-04-29
Registered in v-safe
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-11
-
2021-05-18
Survey response — day 21, dose 1MedDRA: Dysmenorrhoea, Heavy menstrual bleeding, Lymphadenopathy, Menstrual disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Extremely heavy and painful period that lasted longer then normal (and was a little late). Swollen lymphs under left armpit.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-19
Dose 2 — Pfizer-BioNTech
-
2021-05-20
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-05-26
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: FairFree text: Swollen lymphs under both armpitsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-04
- 2021-07-02
- 2021-08-18
- 2021-11-20
-
2021-12-03
Dose 3 — Pfizer-BioNTech
-
2021-12-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · None · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-07
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · HeadacheFree text: Swollen lymph node under armpit with shotMedDRA releases: 2024-11 · check-in free text available
- 2021-12-08
- 2021-12-09
- 2021-12-19
-
2022-01-03
Survey response — day 28, dose 3MedDRA: Malaise, SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID symptoms. Tested positiveMedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Survey response — day 35, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID-19 omicronMedDRA releases: 2024-11 · check-in free text available
-
2022-03-06
Survey response — 3 months, dose 3MedDRA: Nasopharyngitis, Pre-existing disease, SARS-CoV-2 test negative — Feeling: GoodFree text: I have a cold, but it's not Covid. I tested 3 times. I've been boosted in Dec and had Covid in January.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-05
-
2022-12-04
Survey response — 12 months, dose 3MedDRA: Cough, Pneumonia, SARS-CoV-2 test negative — Feeling: Good · Be unable to do your normal daily activitiesFree text: I had a bad lung infection about a month ago. It was not Covid. Have a cough still from it.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-27 | Pfizer-BioNTech | |
| 2 | 2021-05-19 | Pfizer-BioNTech | |
| 3 | 2021-12-03 | Pfizer-BioNTech | No |
Free text
Release 8 — day 21, dose 1
Symptoms: Extremely heavy and painful period that lasted longer then normal (and was a little late). Swollen lymphs under left armpit.
Release 8 — day 7, dose 2
Systemic reaction (other): Swollen lymphs under both armpits
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymph node under armpit with shot
Release 10 — day 28, dose 3
Symptoms: COVID symptoms. Tested positive
Release 10 — day 35, dose 3
Symptoms: COVID-19 omicron
Release 11 — 3 months, dose 3
Symptoms: I have a cold, but it's not Covid. I tested 3 times. I've been boosted in Dec and had Covid in January.
Release 12 — 12 months, dose 3
Symptoms: I had a bad lung infection about a month ago. It was not Covid. Have a cough still from it.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dysmenorrhoea | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release